BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 8542581)

  • 1. Platelet-derived growth factor-B/v-sis confers a tumorigenic and metastatic phenotype to human T98G glioblastoma cells.
    Potapova O; Fakhrai H; Baird S; Mercola D
    Cancer Res; 1996 Jan; 56(2):280-6. PubMed ID: 8542581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth factor PDGF-B/v-sis confers a tumorigenic phenotype to human tumor cells bearing PDGF receptors but not to cells devoid of receptors: evidence for an autocrine, but not a paracrine, mechanism.
    Potapova O; Fakhrai H; Mercola D
    Int J Cancer; 1996 May; 66(5):669-77. PubMed ID: 8647631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet-derived growth factor in human malignancy.
    Silver BJ
    Biofactors; 1992 Apr; 3(4):217-27. PubMed ID: 1318717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imbalanced expression of cellular nuclear oncogenes caused by v-sis/PDGF-2.
    Sonobe MH; Bravo R; Armelin MS
    Oncogene; 1991 Sep; 6(9):1531-7. PubMed ID: 1923519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of brain tumors in mice using a recombinant platelet-derived growth factor B-chain retrovirus.
    Uhrbom L; Hesselager G; Nistér M; Westermark B
    Cancer Res; 1998 Dec; 58(23):5275-9. PubMed ID: 9850047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of platelet-derived growth factor B/c-sis by the v-erbA oncogene in glial cells.
    Iglesias T; Llanos S; López-Barahona M; Seliger B; Rodríguez-Peña A; Bernal J; Muñoz A
    Oncogene; 1995 Mar; 10(6):1103-10. PubMed ID: 7700635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transformation of diploid human fibroblasts by DNA transfection with the v-sis oncogene.
    Fry DG; Milam LD; Maher VM; McCormick JJ
    J Cell Physiol; 1986 Aug; 128(2):313-21. PubMed ID: 3015989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The sis gene and PDGF.
    Williams LT
    Cancer Surv; 1986; 5(2):233-41. PubMed ID: 3536086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PDGF-D is a potent transforming and angiogenic growth factor.
    Li H; Fredriksson L; Li X; Eriksson U
    Oncogene; 2003 Mar; 22(10):1501-10. PubMed ID: 12629513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of platelet-derived growth factor B-chain and the platelet-derived growth factor receptor beta subunit in human breast tissue and breast carcinoma.
    Coltrera MD; Wang J; Porter PL; Gown AM
    Cancer Res; 1995 Jun; 55(12):2703-8. PubMed ID: 7780988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet-derived growth factor-B increases colon cancer cell growth in vivo by a paracrine effect.
    Hsu S; Huang F; Friedman E
    J Cell Physiol; 1995 Nov; 165(2):239-45. PubMed ID: 7593201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. c-sis/platelet-derived growth factor-B promoter requirements for induction during the 12-O-tetradecanoylphorbol-13-acetate-mediated megakaryoblastic differentiation of K562 human erythroleukemia cells.
    Kujoth GC; Fahl WE
    Cell Growth Differ; 1997 Sep; 8(9):963-77. PubMed ID: 9300179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alanine mutagenesis of conserved residues in the platelet-derived growth factor family: identification of residues necessary for dimerization and transformation.
    Maher DW; Strawn LM; Donoghue DJ
    Oncogene; 1993 Mar; 8(3):533-41. PubMed ID: 8437840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of c-sis (PDGF B-chain) and PDGF A-chain genes in ten human malignant mesothelioma cell lines derived from primary and metastatic tumors.
    Versnel MA; Hagemeijer A; Bouts MJ; van der Kwast TH; Hoogsteden HC
    Oncogene; 1988 Jun; 2(6):601-5. PubMed ID: 3290807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of platelet-derived growth factor-mediated signal transduction and tumor growth by N-[4-(trifluoromethyl)-phenyl]5-methylisoxazole-4-carboxamide.
    Shawver LK; Schwartz DP; Mann E; Chen H; Tsai J; Chu L; Taylorson L; Longhi M; Meredith S; Germain L; Jacobs JS; Tang C; Ullrich A; Berens ME; Hersh E; McMahon G; Hirth KP; Powell TJ
    Clin Cancer Res; 1997 Jul; 3(7):1167-77. PubMed ID: 9815796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transformation suppressor activity of C3G is independent of its CDC25-homology domain.
    Guerrero C; Fernandez-Medarde A; Rojas JM; Font de Mora J; Esteban LM; Santos E
    Oncogene; 1998 Feb; 16(5):613-24. PubMed ID: 9482107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective expression of mRNA encoding platelet-derived growth factor B chain following transfection of foreign genes into cell lines derived from baby hamster kidney.
    Sakariassen KS; Powell JS; Raines EW; Ross R
    J Cell Biochem; 1989 Jan; 39(1):87-94. PubMed ID: 2654148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Normal developing rat brain expresses a platelet-derived growth factor B chain (c-sis) mRNA truncated at the 5' end.
    Sasahara M; Amano S; Sato H; Yang JG; Hayase Y; Kaneko M; Sato I; Suzaki M; Hazama F
    Oncogene; 1998 Mar; 16(12):1571-8. PubMed ID: 9569024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. v-sis oncogene-induced transformation of human fibroblasts into cells capable of forming benign tumors.
    Yang D; Kohler SK; Maher VM; McCormick JJ
    Carcinogenesis; 1994 Oct; 15(10):2167-75. PubMed ID: 7955050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of PDGF-2 homodimers in human tumor cells.
    Igarashi H; Rao CD; Siroff M; Leal F; Robbins KC; Aaronson SA
    Oncogene; 1987 Mar; 1(1):79-85. PubMed ID: 3325876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.